Skip to main content

Table 4 Costs and benefits from provider perspective and societal perspective

From: Effectiveness and economic analysis of the whole cell/recombinant B subunit (WC/rbs) inactivated oral cholera vaccine in the prevention of traveller's diarrhoea

  Perspective
Costs per 1000 travellers Provider Societal
Vaccination (Vaccine+IVC) 57,210.00 57,210.00
Disease without vaccination 26,931.30 214,637.01
Disease with vaccination 57,889.42 135,356.56
Net saving -30,958.12 79,280.45
Benefit-cost ratio - 1.39